Abstract
Endophthalmitis incidence and clinical characteristics was reported to change during Covid-19 pandemic, due to multiple influencing factors, such as prolonged lockdown periods, persistent immune suppression following Sars-Cov-2 infection, and mask wearing. We conducted a retrospective eight-year study, during January 2016 and December 2023, that aims to investigates the differences in terms of etiology, clinical characteristics and outcomes in cases with acute endophthalmitis, admitted before (2016-2019) and during Covid-19 pandemic (2020-2023). The two study subgroups were homogenous in term of age, gender distribution, associated comorbidities, and addressability. During Covid-19 pandemic there were significant delays in presentation (p=0.02), more cases of endogenous endophthalmitis (p=0.025), and patients presented a more intense systemic inflammatory reaction (p
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Recommended Citation
Dascalu, Ana Maria; Jurja, Sanda; Mocanu, Carmen Luminita; Alexandrescu, Cristina; Stana, Daniela; Totir, Madalina; Ergin, Ece; Tudor, Corneliu; Grigorescu, Catalin Cicerone; Serban, Dragos; Simion, Laurentiu; Dumitrescu, Dan; Marin, Andrei; Constantinescu, Catalin Teodor; and Cristea, Bogdan Mihai
(2024)
"Effects of the COVID-19 pandemic on clinical manifestations and therapeutic outcomes in acute endophthalmitis,"
Journal of Mind and Medical Sciences: Vol. 11:
Iss.
2, Article 26.
DOI: https://doi.org/10.22543/2392-7674.1554
Available at:
https://scholar.valpo.edu/jmms/vol11/iss2/26